NYSE:LLY
Eli Lilly and Company
- Stock
Share Trends
Recent Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
Sulzberger Gabrielle Director Common Stock | 2024-04-16 | 13 0.61% |
Alvarez Ralph Director Common Stock | 2024-04-16 | 16 0.03% |
Johnson Kimberly H Director Common Stock | 2024-04-16 | 13 0.50% |
Hedley Mary Lynne Director Common Stock | 2024-04-16 | 13 0.89% |
Luciano Juan R Director Common Stock | 2024-04-16 | 20 0.13% |
Largest Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
Lilly Endowment Inc Director Common Stock | 2019-11-25 | -251.74K −0.22% |
Lilly Endowment Inc Director Common Stock | 2021-06-11 | -240K −0.22% |
Lilly Endowment Inc Director Common Stock | 2021-08-04 | -236.54K −0.22% |
Lilly Endowment Inc Director Common Stock | 2020-04-13 | -230K −0.20% |
Lilly Endowment Inc Director Common Stock | 2023-05-01 | -225K −0.22% |
Transaction Log
| Filing Date | Transaction Date | Reporter | Title | Post Shares | Quantity | T | Stock Class | USD |
|---|---|---|---|---|---|---|---|---|
2024-04-16 | 2024-04-15 | Hedley Mary Lynne | Director | 1.48K | 13 | A | Common Stock | 9.76K |
2024-04-16 | 2024-04-15 | Alvarez Ralph | Director | 54.03K | 16 | A | Common Stock | 12.01K |
2024-04-16 | 2024-04-15 | Johnson Kimberly H | Director | 2.63K | 13 | A | Common Stock | 9.76K |
2024-04-16 | 2024-04-15 | Luciano Juan R | Director | 15.68K | 20 | A | Common Stock | 15.02K |
2024-04-16 | 2024-04-15 | Sulzberger Gabrielle | Director | 2.13K | 13 | A | Common Stock | 9.76K |
2024-03-19 | 2024-03-18 | Alvarez Ralph | Director | 54.01K | 15 | A | Common Stock | 11.44K |
2024-03-19 | 2024-03-18 | Hedley Mary Lynne | Director | 1.46K | 13 | A | Common Stock | 9.91K |
2024-03-19 | 2024-03-18 | Sulzberger Gabrielle | Director | 2.12K | 13 | A | Common Stock | 9.91K |
2024-03-19 | 2024-03-18 | Luciano Juan R | Director | 15.66K | 19 | A | Common Stock | 14.49K |
2024-03-19 | 2024-03-18 | Johnson Kimberly H | Director | 2.61K | 13 | A | Common Stock | 9.91K |
2024-03-11 | 2024-03-11 | Zakrowski Donald A | SVP, Finance, & CAO | 7.88K | 750 | S | Common Stock | -565.20K |
2024-02-21 | 2024-02-20 | Sulzberger Gabrielle | Director | 2.10K | 13 | A | Common Stock | 9.82K |
2024-02-21 | 2024-02-20 | Hedley Mary Lynne | Director | 1.45K | 13 | A | Common Stock | 9.82K |
2024-02-21 | 2024-02-20 | Alvarez Ralph | Director | 53.91K | 16 | A | Common Stock | 12.09K |
2024-02-21 | 2024-02-20 | Johnson Kimberly H | Director | 2.60K | 13 | A | Common Stock | 9.82K |
2024-02-21 | 2024-02-20 | Luciano Juan R | Director | 15.61K | 20 | A | Common Stock | 15.11K |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.07M | 1.10K | S | Common Stock | -840.72K |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.00M | 15.44K | S | Common Stock | -12.07M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.02M | 3.94K | S | Common Stock | -3.06M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.02M | 3.21K | S | Common Stock | -2.49M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 98.99M | 9.15K | S | Common Stock | -7.17M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.06M | 2.82K | S | Common Stock | -2.16M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 98.98M | 12.28K | S | Common Stock | -9.63M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.02M | 900 | S | Common Stock | -700.88K |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.03M | 1.80K | S | Common Stock | -1.39M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.05M | 1.20K | S | Common Stock | -923.04K |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.05M | 4.71K | S | Common Stock | -3.62M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 98.90M | 1.39K | S | Common Stock | -1.10M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.01M | 1.18K | S | Common Stock | -919.01K |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.06M | 5.93K | S | Common Stock | -4.55M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 98.90M | 600 | S | Common Stock | -475.23K |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 98.90M | 3.60K | S | Common Stock | -2.85M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 98.93M | 12.78K | S | Common Stock | -10.06M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 98.90M | 10.11K | S | Common Stock | -7.98M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 98.94M | 8.71K | S | Common Stock | -6.85M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 98.95M | 25.13K | S | Common Stock | -19.74M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 98.92M | 13.49K | S | Common Stock | -10.63M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.02M | 1.70K | S | Common Stock | -1.32M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.03M | 1.50K | S | Common Stock | -1.16M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.01M | 2.12K | S | Common Stock | -1.66M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.03M | 2K | S | Common Stock | -1.55M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.06M | 3.47K | S | Common Stock | -2.66M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.03M | 16.80K | S | Common Stock | -12.94M |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 98.90M | 600 | S | Common Stock | -475.85K |
2024-02-20 | 2024-02-16 | Lilly Endowment Inc | Director | 99.02M | 2.04K | S | Common Stock | -1.58M |
2024-02-16 | 2024-02-15 | Lilly Endowment Inc | Director | 99.07M | 1.40K | S | Common Stock | -1.07M |
2024-02-16 | 2024-02-15 | Lilly Endowment Inc | Director | 99.08M | 41.05K | S | Common Stock | -31.21M |
2024-02-16 | 2024-02-15 | Lilly Endowment Inc | Director | 99.07M | 7.86K | S | Common Stock | -5.99M |
2024-02-14 | 2024-02-12 | Dozier Eric | EVP, HR & Diversity | 5.85K | 408 | G | Common Stock | 0 |
2024-02-14 | 2024-02-12 | Zakrowski Donald A | SVP, Finance, & CAO | 8.63K | 1.25K | A | Common Stock | 924.52K |
2024-02-14 | 2024-02-12 | White Anne E. | EVP & Pres, Lilly Neuroscience | 65.57K | 5.36K | A | Common Stock | 3.95M |
2024-02-14 | 2024-02-12 | Van Naarden Jacob | EVP & Pres., Loxo@Lilly | 16.15K | 2.37K | A | Common Stock | 1.75M |
2024-02-14 | 2024-02-12 | Dozier Eric | EVP, HR & Diversity | 7.19K | 1.34K | A | Common Stock | 984.98K |
2024-02-12 | 2024-02-08 | Ricks David A | President, Chair, and CEO | 440.86K | 956 | G | Common Stock | 0 |
2024-02-12 | 2024-02-09 | Lilly Endowment Inc | Director | 99.12M | 4.79K | S | Common Stock | -3.56M |
2024-02-12 | 2024-02-09 | Lilly Endowment Inc | Director | 99.12M | 1.50K | S | Common Stock | -1.12M |
2024-02-12 | 2024-02-09 | Lilly Endowment Inc | Director | 99.12M | 1.87K | S | Common Stock | -1.39M |
2024-02-12 | 2024-02-09 | Lilly Endowment Inc | Director | 99.13M | 30.25K | S | Common Stock | -22.43M |
2024-02-12 | 2024-02-09 | Lilly Endowment Inc | Director | 99.16M | 165.54K | S | Common Stock | -122.55M |
2024-02-12 | 2024-02-09 | Lilly Endowment Inc | Director | 99.12M | 2.30K | S | Common Stock | -1.71M |
2024-02-09 | 2024-02-08 | Lilly Endowment Inc | Director | 99.33M | 8.74K | S | Common Stock | -6.47M |
2024-02-02 | 2024-02-01 | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | 110.83K | 4.43K | F | Common Stock | -2.86M |
2024-02-02 | 2024-02-01 | White Anne E. | EVP & Pres, Lilly Neuroscience | 60.21K | 1.84K | F | Common Stock | -1.19M |
2024-02-02 | 2024-02-01 | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | 115.26K | 9.94K | M | Common Stock | 0 |
2024-02-02 | 2024-02-01 | White Anne E. | EVP & Pres, Lilly Neuroscience | 62.05K | 4.12K | M | Common Stock | 0 |
2024-02-02 | 2024-02-01 | Norton Johna | EVP, Global Quality | 31.38K | 1.27K | M | Common Stock | 0 |
2024-02-02 | 2024-02-01 | Hakim Anat | EVP, GC & Secretary | 26.63K | 4.44K | M | Common Stock | 0 |
2024-02-02 | 2024-02-01 | Hakim Anat | EVP, GC & Secretary | 24.66K | 1.97K | F | Common Stock | -1.27M |
2024-02-02 | 2024-02-01 | Norton Johna | EVP, Global Quality | 30.82K | 566 | F | Common Stock | -365.42K |
2024-02-02 | 2024-02-01 | Van Naarden Jacob | EVP & Pres., Loxo@Lilly | 15.46K | 3.62K | M | Common Stock | 0 |
2024-02-02 | 2024-02-01 | Ricks David A | President, Chair, and CEO | 455.05K | 29.61K | M | Common Stock | 0 |
2024-02-02 | 2024-02-01 | Yuffa Ilya | EVP & President, LLY Int'l | 15.01K | 1.66K | F | Common Stock | -1.07M |
2024-02-02 | 2024-02-01 | Van Naarden Jacob | EVP & Pres., Loxo@Lilly | 13.78K | 1.69K | F | Common Stock | -1.09M |
2024-02-02 | 2024-02-01 | Ricks David A | President, Chair, and CEO | 441.81K | 13.24K | F | Common Stock | -8.55M |
2024-02-02 | 2024-02-01 | Jonsson Patrik | EVP&Pres, LLY Dia&Obe, LLY USA | 39.22K | 1.84K | F | Common Stock | -1.19M |
2024-02-02 | 2024-02-01 | Jonsson Patrik | EVP&Pres, LLY Dia&Obe, LLY USA | 41.06K | 4.12K | M | Common Stock | 0 |
2024-02-02 | 2024-02-01 | Yuffa Ilya | EVP & President, LLY Int'l | 16.68K | 3.70K | M | Common Stock | 0 |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.35M | 7.42K | S | Common Stock | -4.82M |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.36M | 8.70K | S | Common Stock | -5.63M |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.34M | 1.70K | S | Common Stock | -1.12M |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.35M | 4.93K | S | Common Stock | -3.20M |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.38M | 35.51K | S | Common Stock | -22.91M |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.37M | 9.17K | S | Common Stock | -5.93M |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.34M | 1.70K | S | Common Stock | -1.12M |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.33M | 200 | S | Common Stock | -132.33K |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.33M | 500 | S | Common Stock | -331.40K |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.34M | 600 | S | Common Stock | -394.44K |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.34M | 900 | S | Common Stock | -586.40K |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.34M | 797 | S | Common Stock | -525.73K |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.35M | 815 | S | Common Stock | -530.34K |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.34M | 1.90K | S | Common Stock | -1.24M |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.34M | 2.75K | S | Common Stock | -1.80M |
2024-02-01 | 2024-01-31 | Lilly Endowment Inc | Director | 99.33M | 985 | S | Common Stock | -651.17K |
2024-01-31 | 2024-01-30 | Lilly Endowment Inc | Director | 99.42M | 69.37K | S | Common Stock | -44.75M |
2024-01-31 | 2024-01-30 | Lilly Endowment Inc | Director | 99.41M | 6.84K | S | Common Stock | -4.42M |
2024-01-30 | 2024-01-29 | Lilly Endowment Inc | Director | 99.49M | 54.03K | S | Common Stock | -34.85M |
2024-01-17 | 2024-01-16 | Luciano Juan R | Director | 15.59K | 23 | A | Common Stock | 14.60K |
2024-01-17 | 2024-01-16 | Hedley Mary Lynne | Director | 1.44K | 16 | A | Common Stock | 10.15K |
2024-01-17 | 2024-01-16 | Alvarez Ralph | Director | 53.89K | 19 | A | Common Stock | 12.06K |
2024-01-17 | 2024-01-16 | Lilly Endowment Inc | Director | 99.54M | 1.08K | S | Common Stock | -697.19K |